Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Emory University School of Medicine

Headquarters: Atlanta, GA, United States of America
Year Founded: 1915
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Dec 19, 2024
Discovery & Translation

Science Spotlight: Platelets as targeted protein degraders 

BioCentury’s roundup of translational innovations also includes ribonucleoproteins delivery and fine-tuning TCR specificity
BioCentury | Aug 30, 2023
Discovery & Translation

Midnolin-proteasome pathway; plus inhibitory receptor on T cells and more

BioCentury’s roundup of translational innovations
BioCentury | Apr 1, 2022
Distillery Therapeutics

Blocking FSH for Alzheimer’s disease

BioCentury | Aug 27, 2021
Distillery Therapeutics

Targeting MAST1 to restore cisplatin sensitivity in cancer

BioCentury | Sep 10, 2020
Regulation

FDA will require data similar to BLA standard for COVID-19 emergency authorization

FDA officials vow rigorous standards for COVID-19 vaccines
BioCentury | Feb 20, 2019
Distillery Therapeutics

Autoimmune disease

BioCentury | Dec 12, 2018
Distillery Therapeutics

Neurology

BioCentury | Dec 12, 2018
Distillery Therapeutics

Cancer

Items per page:
1 - 10 of 109